MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/jnci/djaa040

Медицинская библиотека · Journal of the National Cancer Institute · 2020

Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women.

Palmer Julie R, Polley Eric C, Hu Chunling, John Esther M, Haiman Christopher, Hart Steven N, Gaudet Mia, Pal Tuya, Anton-Culver Hoda, Trentham-Dietz Amy, Bernstein Leslie, Ambrosone Christine B, Bandera Elisa V, Bertrand Kimberly A, Bethea Traci N, Gao Chi, Gnanaolivu Rohan D, Huang Hongyan, Lee Kun Y, LeMarchand Loic, Na Jie, Sandler Dale P, Shah Payal D, Yadav Siddhartha, Yang William, Weitzel Jeffrey N, Domchek Susan M, Goldgar David E, Nathanson Katherine L, Kraft Peter, Yao Song, Couch Fergus J

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

The risks of breast cancer in African American (AA) women associated with inherited mutations in breast cancer predisposition genes are not well defined. Thus, whether multigene germline hereditary cancer testing panels are applicable to this population is unknown. We assessed associations between mutations in panel-based genes and breast cancer risk in 5054 AA women with breast cancer and 4993 unaffected AA women drawn from 10 epidemiologic studies.

METHODS

Germline DNA samples were sequenced for mutations in 23 cancer predisposition genes using a QIAseq multiplex amplicon panel. Prevalence of mutations and odds ratios (ORs) for associations with breast cancer risk were estimated with adjustment for study design, age, and family history of breast cancer.

RESULTS

Pathogenic mutations were identified in 10.3% of women with estrogen receptor (ER)-negative breast cancer, 5.2% of women with ER-positive breast cancer, and 2.3% of unaffected women. Mutations in BRCA1, BRCA2, and PALB2 were associated with high risks of breast cancer (OR = 47.55, 95% confidence interval [CI] = 10.43 to >100; OR = 7.25, 95% CI = 4.07 to 14.12; OR = 8.54, 95% CI = 3.67 to 24.95, respectively). RAD51D mutations were associated with high risk of ER-negative disease (OR = 7.82, 95% CI = 1.61 to 57.42). Moderate risks were observed for CHEK2, ATM, ERCC3, and FANCC mutations with ER-positive cancer, and RECQL mutations with all breast cancer.

CONCLUSIONS

The study identifies genes that predispose to breast cancer in the AA population, demonstrates the validity of current breast cancer testing panels for use in AA women, and provides a basis for increased referral of AA patients for cancer genetic testing.

Для цитирования: Palmer Julie R, Polley Eric C, Hu Chunling, John Esther M, Haiman Christopher, Hart Steven N, Gaudet Mia, Pal Tuya, Anton-Culver Hoda, Trentham-Dietz Amy, Bernstein Leslie, Ambrosone Christine B, Bandera Elisa V, Bertrand Kimberly A, Bethea Traci N, Gao Chi, Gnanaolivu Rohan D, Huang Hongyan, Lee Kun Y, LeMarchand Loic, Na Jie, Sandler Dale P, Shah Payal D, Yadav Siddhartha, Yang William, Weitzel Jeffrey N, Domchek Susan M, Goldgar David E, Nathanson Katherine L, Kraft Peter, Yao Song, Couch Fergus J. Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women.. Journal of the National Cancer Institute. 2020. DOI: 10.1093/jnci/djaa040.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.